These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34215018)

  • 21. [Efficacy and safety of less invasive surfactant administration in the treatment of neonatal respiratory distress syndrome: a Meta analysis].
    Huo MY; Mei H; Zhang YH; Liu CZ; Hu YN; Song D
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):721-727. PubMed ID: 32669168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of methods for surfactant administration: a network meta-analysis.
    Bellos I; Fitrou G; Panza R; Pandita A
    Arch Dis Child Fetal Neonatal Ed; 2021 Sep; 106(5):474-487. PubMed ID: 33452218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimally invasive surfactant administration in preterm infants: a meta-narrative review.
    More K; Sakhuja P; Shah PS
    JAMA Pediatr; 2014 Oct; 168(10):901-8. PubMed ID: 25089718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: a systematic review and meta-analyses.
    Silveira RC; Panceri C; Munõz NP; Carvalho MB; Fraga AC; Procianoy RS
    J Pediatr (Rio J); 2024; 100(1):8-24. PubMed ID: 37353207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
    Tang W; Chen S; Shi D; Ai T; Zhang L; Huang Y; Fan Y; Du Y
    Pediatr Pulmonol; 2022 Feb; 57(2):455-469. PubMed ID: 34783192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1997(2):CD000511. PubMed ID: 10796380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences.
    Krajewski P; Chudzik A; Strzałko-Głoskowska B; Górska M; Kmiecik M; Więckowska K; Mesjasz A; Sieroszewski P
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1161-4. PubMed ID: 25065621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant delivery via thin catheters: Methods, limitations, and outcomes.
    Devi U; Pandita A
    Pediatr Pulmonol; 2021 Oct; 56(10):3126-3141. PubMed ID: 34379878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does surfactant nebulization prevent early intubation in preterm infants? A protocol for a systematic review and meta-analysis.
    Gaertner VD; Bassler D; Rüegger CM
    Syst Rev; 2021 Jan; 10(1):9. PubMed ID: 33407775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous distending pressure for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF; Blanco F
    Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD001079. PubMed ID: 20091513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H; Xu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premedication with Fentanyl for Less Invasive Surfactant Application (LISA): A Randomized Controlled Trial.
    Sk H; Saha B; Mukherjee S; Hazra A
    J Trop Pediatr; 2022 Feb; 68(2):. PubMed ID: 35201358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.